| First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics B Wu, K Kulkarni, S Basu, S Zhang, M Hu Journal of pharmaceutical sciences 100 (9), 3655-3681, 2011 | 339 | 2011 |
| REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis S Wang, Y Lin, X Yuan, F Li, L Guo, B Wu Nature communications 9 (1), 4246, 2018 | 250 | 2018 |
| Human cytosolic glutathione transferases: structure, function, and drug discovery B Wu, D Dong Trends in pharmacological sciences 33 (12), 656-668, 2012 | 243 | 2012 |
| Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis B Wu, S Basu, S Meng, X Wang, M Hu Current drug metabolism 12 (9), 900-916, 2011 | 117 | 2011 |
| Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns X Zhang, H Wang, Z Ma, B Wu Expert opinion on drug metabolism & toxicology 10 (12), 1691-1702, 2014 | 109 | 2014 |
| Targeting REV-ERBα for therapeutic purposes: promises and challenges S Wang, F Li, Y Lin, B Wu Theranostics 10 (9), 4168, 2020 | 98 | 2020 |
| Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC–MS/MS method: Application to an oral bioavailability study of … Z Yang, W Zhu, S Gao, H Xu, B Wu, K Kulkarni, R Singh, L Tang, M Hu Journal of pharmaceutical and biomedical analysis 53 (1), 81-89, 2010 | 96 | 2010 |
| Circadian rhythm in pharmacokinetics and its relevance to chronotherapy D Dong, D Yang, L Lin, S Wang, B Wu Biochemical Pharmacology 178, 114045, 2020 | 83 | 2020 |
| Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents M Chen, X Lei, C Shi, M Huang, X Li, B Wu, Z Li, W Han, B Du, J Hu, ... The Journal of clinical investigation 127 (10), 3689-3701, 2017 | 82 | 2017 |
| Three-component Pd/Cu-catalyzed cascade reactions of cyclic iodoniums, alkynes, and boronic acids: an approach to methylidenefluorenes D Zhu, Y Wu, B Wu, B Luo, A Ganesan, FH Wu, R Pi, P Huang, S Wen Organic letters 16 (9), 2350-2353, 2014 | 79 | 2014 |
| Enhancement of oral bioavailability of 20 (S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms Z Yang, S Gao, J Wang, T Yin, Y Teng, B Wu, M You, Z Jiang, M Hu Drug Metabolism and Disposition 39 (10), 1866-1872, 2011 | 77 | 2011 |
| Substrate inhibition kinetics in drug metabolism reactions B Wu Drug metabolism reviews 43 (4), 440-456, 2011 | 76 | 2011 |
| Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique Y Ye, X Zhang, T Zhang, H Wang, B Wu Drug development and industrial pharmacy 41 (9), 1416-1424, 2015 | 75 | 2015 |
| Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption X Zhou, X Zhang, Y Ye, T Zhang, H Wang, Z Ma, B Wu International journal of pharmaceutics 479 (2), 391-398, 2015 | 75 | 2015 |
| Structure‐based drug design of catechol‐O‐methyltransferase inhibitors for CNS disorders Z Ma, H Liu, B Wu British journal of clinical pharmacology 77 (3), 410-420, 2014 | 75 | 2014 |
| Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect W Deng, H Wang, B Wu, X Zhang Acta pharmaceutica sinica B 9 (1), 74-86, 2019 | 74 | 2019 |
| Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism W Deng, Q Xie, H Wang, Z Ma, B Wu, X Zhang Nanomedicine: nanotechnology, biology and medicine 13 (6), 1965-1974, 2017 | 74 | 2017 |
| Use of glucuronidation fingerprinting to describe and predict mono-and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes L Tang, L Ye, R Singh, B Wu, C Lv, J Zhao, Z Liu, M Hu Molecular pharmaceutics 7 (3), 664-679, 2010 | 68 | 2010 |
| Small heterodimer partner regulates circadian cytochromes p450 and drug-induced hepatotoxicity T Zhang, F Yu, L Guo, M Chen, X Yuan, B Wu Theranostics 8 (19), 5246, 2018 | 67 | 2018 |
| REV-ERBα regulates CYP7A1 through repression of liver receptor homolog-1 T Zhang, M Zhao, D Lu, S Wang, F Yu, L Guo, S Wen, B Wu Drug Metabolism and Disposition 46 (3), 248-258, 2018 | 66 | 2018 |
